Nyxoah (NYXH) Cash from Financing Activities (2021 - 2026)
Nyxoah (NYXH) posted quarterly Cash from Financing Activities of $468298.3 for Q1 2026, down 39.01% year-over-year from $767875.6 in Q1 2025, and down 98.9% quarter-over-quarter from $42.6 million in Q4 2025.
Nyxoah (NYXH) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Nyxoah's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $468298.3 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 39.01% year-over-year to $468298.3; the TTM figure through Mar 2026 stood at $44.1 million (down 47.49% YoY), while the FY2025 annual figure was $44.4 million, down 46.4% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $468298.3, down from $42.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $48.2 million in Q2 2024, with the low at -$2.2 million in Q2 2025.
- The 5-year median for Cash from Financing Activities is $468298.3 (2026), against an average of $8.5 million.
- Peak annual rise in Cash from Financing Activities reached 9839.52% in 2023, while the deepest fall reached 245.75% in 2023.
- Nyxoah's Cash from Financing Activities stood at -$223434.2 in 2022, then sank by 245.75% to -$772524.9 in 2023, then surged by 3333.35% to $25.0 million in 2024, then surged by 70.56% to $42.6 million in 2025, then sank by 98.9% to $468298.3 in 2026.
- Business Quant data shows NYXH's Cash from Financing Activities at $468298.3 in Q1 2026, $42.6 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | 102.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.97 Mn |
| Jun 30, 2026 | 102.97 Mn |
| Mar 31, 2026 | 468,298.26 |
| Mar 31, 2026 | 468,298.26 |
| Dec 31, 2025 | 42.60 Mn |
| Dec 31, 2025 | 42.60 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -2.19 Mn |
| Mar 31, 2025 | 767,875.64 |
| Mar 31, 2025 | 767,875.64 |
| Dec 31, 2024 | 24.98 Mn |
| Dec 31, 2024 | 24.98 Mn |
| Sep 30, 2024 | 9.98 Mn |
| Sep 30, 2024 | 9.98 Mn |
| Jun 30, 2024 | 48.17 Mn |
| Jun 30, 2024 | 48.17 Mn |
| Mar 31, 2024 | 274,849.53 |
| Mar 31, 2024 | 274,849.53 |